AAAAAA
Results:
1-23
|
Results: 23
Authors:
Parkinson, C
Trainer, PJ
Citation: C. Parkinson et Pj. Trainer, The place of pegvisomant in the management of acromegaly, EXPERT OP I, 10(9), 2001, pp. 1725-1735
Authors:
Klibanski, A
Ho, K
Freda, PU
Clemmons, DR
Barkan, AL
Kleinberg, DL
Trainer, PJ
Swearingen, B
Molitch, ME
Wass, JAH
Thorner, MO
Melmed, S
Strasburger, CJ
Frohman, LA
Citation: A. Klibanski et al., State-of-the-art strategies for the diagnosis and management of acromegaly, ENDOCRINOLO, 11(3), 2001, pp. 223-232
Authors:
Drake, WM
Parkinson, C
Besser, GM
Trainer, PJ
Citation: Wm. Drake et al., Clinical use a of growth hormone receptor antagonist in the treatment of acromegaly, TRENDS ENDO, 12(9), 2001, pp. 408-413
Authors:
Drake, WM
Parkinson, C
Akker, SA
Monson, JP
Besser, GM
Trainer, PJ
Citation: Wm. Drake et al., Successful treatment of resistant acromegaly with a growth hormone receptor antagonist, EUR J ENDOC, 145(4), 2001, pp. 451-456
Authors:
van der Lely, AJ
Hutson, RK
Trainer, PJ
Besser, GM
Barkan, AL
Katznelson, L
Klibanski, A
Herman-Bonert, V
Melmed, S
Vance, ML
Freda, PU
Stewart, PM
Friend, KE
Clemmons, DR
Johannsson, G
Stavrou, S
Cook, DM
Phillips, LS
Strasburger, CJ
Hacker, S
Zib, KA
Davis, RJ
Scarlett, JA
Thorner, M
Citation: Aj. Van Der Lely et al., Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist, LANCET, 358(9295), 2001, pp. 1754-1759
Authors:
Trainer, PJ
Drake, WM
Perry, LA
Taylor, NF
Besser, GM
Monson, JP
Citation: Pj. Trainer et al., Modulation of cortisol metabolism by the growth hormone receptor antagonist pegvisomant in patients with acromegaly, J CLIN END, 86(7), 2001, pp. 2989-2992
Authors:
Kaltsas, GA
Isidori, AM
Florakis, D
Trainer, PJ
Camacho-Hubner, C
Afshar, F
Sabin, I
Jenkins, JP
Chew, SL
Monson, JP
Besser, GM
Grossman, AB
Citation: Ga. Kaltsas et al., Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity, J CLIN END, 86(4), 2001, pp. 1645-1652
Authors:
Parkinson, C
Ryder, WDJ
Trainer, PJ
Citation: C. Parkinson et al., The relationship between serum GH and serum IGF-I in acromegaly is gender-specific, J CLIN END, 86(11), 2001, pp. 5240-5244
Authors:
Parkinson, C
Trainer, PJ
Citation: C. Parkinson et Pj. Trainer, Pegvisomant: a growth hormone receptor antagonist for the treatment of acromegaly, GROWTH H I, 10, 2000, pp. 119-123
Authors:
Kaltsas, GA
Korbonits, M
Isidori, AM
Webb, JAW
Trainer, PJ
Monson, JP
Besser, GM
Grossman, AB
Citation: Ga. Kaltsas et al., How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?, CLIN ENDOCR, 53(4), 2000, pp. 493-500
Authors:
Johnston, LB
Chew, SL
Trainer, PJ
Reznek, R
Grossman, AB
Besser, GM
Monson, JP
Savage, MO
Citation: Lb. Johnston et al., Screening children at risk of developing inherited endocrine neoplasia syndromes, CLIN ENDOCR, 52(2), 2000, pp. 127-136
Authors:
Trainer, PJ
Drake, WM
Katznelson, L
Freda, PU
Herman-Bonert, V
van der Lely, AJ
Dimaraki, EV
Stewart, PM
Friend, KE
Vance, ML
Besser, GM
Scarlett, JA
Thorner, MO
Parkinson, C
Klibanski, A
Powell, JS
Barkan, AL
Sheppard, MC
Maldonado, M
Rose, DR
Clemmons, DR
Johannson, G
Bengtsson, BA
Stavrou, S
Kleinberg, DL
Cook, DM
Phillips, LS
Bidlingmaier, M
Strasburger, CJ
Hackett, S
Zib, K
Bennett, WF
Davis, RJ
Citation: Pj. Trainer et al., Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant, N ENG J MED, 342(16), 2000, pp. 1171-1177
Authors:
Kaltsas, GA
Newell-Price, JDC
Trainer, PJ
Besser, GM
Grossman, AB
Citation: Ga. Kaltsas et al., Complications of inferior petrosel sinus sampling, J CLIN END, 85(4), 2000, pp. 1741-1741
Authors:
Parkinson, C
Trainer, PJ
Citation: C. Parkinson et Pj. Trainer, Growth hormone receptor antagonists therapy for acromegaly, BEST PRAC R, 13(3), 1999, pp. 419-430
Authors:
Islam, N
Trainer, PJ
Citation: N. Islam et Pj. Trainer, The hormonal assessment of the infertile male (vol 82, pg 69, 1999), BJU INT, 83(6), 1999, pp. 739-739
Authors:
Korbonits, M
Little, JA
Forsling, ML
Tringali, G
Costa, A
Navarra, P
Trainer, PJ
Grossman, AB
Citation: M. Korbonits et al., The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants, J NEUROENDO, 11(7), 1999, pp. 521-528
Authors:
Sohaib, SA
Hanson, JA
Newell-Price, JDC
Trainer, PJ
Monson, JP
Grossman, AB
Besser, GM
Reznek, RH
Citation: Sa. Sohaib et al., CT appearance of the adrenal glands in adrenocorticotrophic hormone-dependent Cushing's syndrome, AM J ROENTG, 172(4), 1999, pp. 997-1002
Authors:
Trainer, PJ
Palermo, M
Kirk, JMW
Fanciulli, G
Perry, LH
Delitala, G
Besser, GM
Citation: Pj. Trainer et al., Quantitative growth hormone secretion and final adult height, CLIN ENDOCR, 51(5), 1999, pp. 597-602
Authors:
Korbonits, M
Kaltsas, G
Perry, LA
Grossman, AB
Monson, JP
Besser, GM
Trainer, PJ
Citation: M. Korbonits et al., Hexarelin as a test of pituitary reserve in patients with pituitary disease, CLIN ENDOCR, 51(3), 1999, pp. 369-375
Authors:
Korbonits, M
Kaltsas, G
Perry, LA
Putignano, P
Grossman, AB
Besser, GM
Trainer, PJ
Citation: M. Korbonits et al., The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin, J CLIN END, 84(7), 1999, pp. 2489-2495
Authors:
Kaltsas, GA
Giannulis, MG
Newell-Price, JDC
Dacie, JE
Thakkar, C
Afshar, F
Monson, JP
Grossman, AB
Besser, GM
Trainer, PJ
Citation: Ga. Kaltsas et al., A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing's disease and the occult ectopic adrenocorticotropin syndrome, J CLIN END, 84(2), 1999, pp. 487-492
Authors:
Hanson, JA
Sohaib, SA
Newell-Price, J
Islam, N
Monson, JP
Trainer, PJ
Grossman, A
Besser, GM
Reznek, RH
Citation: Ja. Hanson et al., Computed tomography appearance of the thymus and anterior mediastinum in active Cushing's syndrome, J CLIN END, 84(2), 1999, pp. 602-605
Authors:
Jenkins, PJ
Sohaib, SA
Trainer, PJ
Lister, TA
Besser, GM
Reznek, R
Citation: Pj. Jenkins et al., Adrenal enlargement and failure of suppression of circulating cortisol by dexamethasone in patients with malignancy, BR J CANC, 80(11), 1999, pp. 1815-1819
Risultati:
1-23
|